Background
==========

The human genome project has generated raw information on an increasing number of novel genes and gene families whose function is still unknown. Positional cloning and large-scale genome analysis allow preliminary functional assignment of human genes on the basis of linkage to genetic diseases and reported information from model organisms. Although the available computational tools may fail to provide clear functional clues, they are still of great value in defining structural domains, pinpointing intra- and interspecific sequence homologies and establishing new gene families. In the human genome, a mutational approach to characterizing genes functionally is limited to patients that carry well characterized disease alleles. On the other hand, the availability of the mouse genome sequence is providing new tools for systematic functional characterization. This approach has already been used in yeast by the European Functional Analysis Network (EUROFAN) and has provided functional insights on evolutionarily conserved genes.

We previously reported linkage of autosomal recessive retinitis pigmentosa (*RP26*) to chromosome 2q31-33, between markers D2S148 and D2S117 \[[@B1]\]. Subsequent analyses narrowed the locus to the D2S350-D2S161 interval. This chromosomal region, (approximately 8 million base pairs (Mbp)) is characterized by a low percentage of G+C - basically made of L1+L2 isochores - and by sparse gene content \[[@B2]\]. As no obvious positional candidates were found among known genes, an expressed sequence tag (EST) database search was undertaken to identify sequences expressed in the retina. One of the identified ESTs was homologous with two yeast open reading frames (ORFs), two predicted genes in *Arabidopsis* and one in *Drosophila* and other human genomic and EST sequences. After full cDNA analyses and characterization of the corresponding genomic regions, a functional approach was undertaken. We report here a new evolutionarily conserved gene family, named *ORMDL,* for *ORM1* (*Saccharomyces cerevisiae*)-like genes, following the HUGO Gene Nomenclature Committee guidelines, and present what could be called a \'vertical\' genomics approach in several model organisms. This comprises subcellular localization of the encoded proteins, expression analyses on human tissues and *Drosophila* embryos, and single and double yeast knockouts.

Results
=======

Characterization of the full-length human *ORMDL1* cDNA
-------------------------------------------------------

A human retinal cDNA library was screened using a 647 base pair (bp) probe containing the WI-18706 STS (located at the *RP26* locus, see Materials and methods). A total of 13 positive clones were isolated, subcloned in pBluescript II KS(+), and sequenced (Figure [1](#F1){ref-type="fig"}). Eight of the clones contained an apparently complete ORF, and the other five were truncated. The 5\' and 3\' ends of the messages were verified by rapid amplification of cDNA ends (RACE) using placental RNA as template. In the 5\' experiment, two extended products were detected with the same 5\' end but a differentially spliced 110 bp non-coding exon. The longer RACE product started 175 bp upstream of a putative initiation codon and this 5\' untranslated region (5\'-UTR) contained two in-frame stop codons. The shorter RACE product did not contain an in-frame stop codon. In the 3\' experiment, a single extension product was detected which contained a polyadenylation signal (ATTAAA) situated 24 nucleotides 5\' of the poly(A) tail. Some of the cDNA clones had an extended 3\'-UTR which could be the result of the use of different polyadenylation signals further downstream. The full-length cDNA (1,092 bp) contained an ORF consisting of 462 bp, from nucleotides 176 to 637. The deduced protein chain consisted of 153 amino acids with an estimated molecular mass of 17.4 kDa.

Characterization of *ORMDL1* homologs cDNAs
-------------------------------------------

When searching the nucleotide databases with the full-length human *ORMDL1* cDNA, human homologous EST sequences were identified which belonged to two separate UniGene clusters (Hs.13144 and Hs.293711). Corresponding IMAGE cDNA clones were obtained and sequenced. The deduced ORFs (denoted *ORMDL2* and *ORMDL3*) had the same size as *ORMDL1.* Comparison of the proteins showed between 80% and 84% positional identities (Table [1](#T1){ref-type="table"}), and 116 out of 153 amino-acid residues were conserved between the three sequences. Moreover, in 26 of the 37 remaining positions the substitutions are conservative.

No homologous sequences were identified in *Drosophila* EST databases. Screening of an adult *Drosophila melanogaster* cDNA library using the human *ORMDL1* cDNA as a heterologous probe was not successful either. We then designed a homologous probe based on the *Drosophila* genomic high-throughput sequence. Five positive clones were isolated and sequenced. Although none of the clones was full-length, one covered more than 80% of the ORF. The complete ORF could then be deduced by overlapping this sequence to the genomic data. The conceptual translated sequence was one amino acid longer at the amino terminus than the human forms and shared between 48% and 50% residue identities. Subsequently, in the completed *Drosophila* Genome Project, this sequence has appeared annotated as *predicted gene CG14577* \[[@B3]\].

*ORMDL1* belongs to an evolutionarily conserved gene family
-----------------------------------------------------------

The *ORMDL1* ORF was used for database sequence comparisons using the National Center for Biotechnology Information (NCBI) BLAST server \[[@B4],[@B5]\] (tBLASTN against nucleotide databases, and BLASTP, PSI-BLAST and PHI-BLAST against the non-redundant protein database). Homologous protein sequences were found in yeast, microsporidia (*Encephalitozoon cuniculi,* an opportunistic pathogen in AIDS), plants (including *Arabidopsis*), invertebrates (*Drosophila*), urochordates (*Ciona intestinalis*) and vertebrates. The search for distant relatives using PSI-BLAST and PHI-BLAST programs and for short, nearly exact, matches (BLASTP) did not yield any additional homologs. In vertebrates, three different genes were distinguished, corresponding to *ORMDL1, ORMDL2* and *ORMDL3. S. cerevisiae* and *A. thaliana* showed two copies each, while a single copy was found in *C. intestinalis, D. melanogaster, Saccharomyces monacensis, Schizosaccharomyces pombe* and *E. cuniculi.* Table [2](#T2){ref-type="table"} lists most of the genes, with their corresponding annotations in the public databases, if available, and summarizes other relevant features.

When all the protein sequences were aligned using CLUSTALW, several conserved domains became evident (Figure [2](#F2){ref-type="fig"}). In addition, all yeast proteins were longer, at both the amino- and carboxy-terminal ends. Pairwise comparisons revealed a very high level of identity (Table [1](#T1){ref-type="table"}). Searches for characterized functional domains did not reveal any significant homology. However, four putative transmembrane domains were detected when considering the protein alignment of all known members of the family. Similar results were obtained when analyzing the ORMDL1 sequence on its own (Figure [2](#F2){ref-type="fig"}).

A phylogenetic tree using all the available protein sequences was drawn with CLUSTALW and the bootstrap values were also calculated (Figure [3](#F3){ref-type="fig"}). According to this tree, each human *ORMDL* gene has an extremely conserved counterpart in all vertebrates analyzed. Vertebrate sequences cluster together in a separate branch. Similarly, yeast, microsporidian and plant ORMDLs group in well differentiated lineages.

Genomic structure of the *ORMDL* sequences
------------------------------------------

The full-length human *ORMDL1* cDNA clone was compared to non-redundant DNA databases and the 5\' end was found to be homologous to the promoter region of the *PMS1* gene \[[@B6]\]. The P1 genomic clone 1670, containing this region, was analyzed by restriction mapping and Southern blot with the *ORMDL1* cDNA as a probe. Positive fragments were sub-cloned and sequenced. The nucleotide sequence contained 4.8 kilobases (kb) of the upstream region, all of the five exons, and the four introns (Figure [4](#F4){ref-type="fig"}). The third intron was not fully sequenced and the size was determined by restriction mapping after amplification by polymerase chain reaction (PCR). All introns were flanked by the consensus donor and acceptor splice sites. No putative TATA box was found on the upstream genomic sequence, although several Sp1-binding sites were detected using the TESS server \[[@B7]\]. Using the EMBL CpG Islands service \[[@B8]\] a presumptive 0.9 kb CpG island containing 0.4 kb of the upstream region, the first exon of the 5\'-UTR, and parts of the first intron was detected.

Database searches against releases of the public Human Genome Project \[[@B4]\] confirmed the genomic *ORMDL1* structure. Furthermore, the genomic structures of the coding region of the two human paralogs *ORMDL2* and *ORMDL3* and the *D. melanogaster* homolog were deduced after alignment of the characterized human and *Drosophila* cDNAs with genomic sequence databases. For the A. *thaliana ORMDL* homolog, tBLASTN searches were carried out with the human ORMDL proteins against the *Arabidopsis* genome. The data obtained were contrasted with gene predictions from the *Arabidopsis* Genome Initiative (actually, one of these predictions has already been confirmed; GenBank accession no. AF360237). In all these genes a genomic structure of three coding exons is totally conserved, including the positions of the exon-intron boundaries ( [4](#F4){ref-type="fig"}). In contrast, the yeast homologs were each encoded in one single continuous ORF. Interestingly, the introns of human *ORMDL2* and *ORMDL3* genes were found to be much smaller than those of *ORMDL1.* The human *ORMDL* homologs mapped to different chromosomes from *ORMDL1 (ORMDL2* to 12q13.2 and *ORMDL3* to 17q21.1). No further human homologs were detected in the public databanks \[[@B4]\] or in the Celera database \[[@B9]\], except for two putative processed pseudogenes. One of these showed 86% positional identity to *ORMDL1* and mapped to chromosome 10p14, and the other showed 84% identity to *ORMDL2* and mapped to 8q22.1. Both ![](gb-2002-3-6-research0027-i1.gif)*ORMDL1* and ![](gb-2002-3-6-research0027-i1.gif)*ORMDL2* lacked introns and appeared to have acquired several indels (insertions/deletions). In addition, ![](gb-2002-3-6-research0027-i1.gif)*ORMDL2* lacked the first coding exon of *ORMDL2.*

Expression analysis of human *ORMDL* genes
------------------------------------------

To study the expression pattern of human *ORMDL* genes, RT-PCR and northern analyses were performed. RT-PCR expression analysis on sixteen adult and fetal tissue samples showed a ubiquitous expression pattern for all three human genes (Figure [5a](#F5){ref-type="fig"}). Northern analysis using full-length as well as 3\'-UTR *ORMDL1* cDNA probes identified three transcripts of 1.4, 2.5 and 3.3 kb in most human adult tissues (Figure [5b](#F5){ref-type="fig"}). The expression of *ORMDL1* was moderately high in pancreas, placenta and brain but low in skeletal muscle and lung.

Subcellular localization of human ORMDL proteins: expression of ORMDL-EGFP fusion proteins in COS-7 cells
---------------------------------------------------------------------------------------------------------

To determine the subcellular localization of the ORMDL proteins, the cDNAs corresponding to the human *ORMDL* genes were cloned into pEGFP-derived vectors and transiently expressed in transfected COS-7 cells. Twenty-four hours after transfection, fusion proteins of enhanced green fluorescent protein and ORMDL (EGFP-ORMDL) appeared predominantly in the perinuclear endoplasmic reticulum (ER) and, to a lesser extent, throughout the extended ER network (Figure [6a](#F6){ref-type="fig"}). Confocal scanning microscopy using an antibody against protein-disulfide isomerase (PDI), an ER-marker protein, showed an overlapping signal in the endoplasmic reticulum (Figure [6a,6b,6c](#F6){ref-type="fig"}). In contrast, double-label fluorescence with biotin-labeled concanavalin A (which shows affinity for terminal α-D-mannosyl and α-D-glucosyl residues, and thus binds to the plasma membrane in non-permeabilized cells), detected with Texas Red-conjugated streptavidin, showed no overlapping signal with EGFP-ORMDL at the plasmatic membrane (Figure [6d,6e,6f](#F6){ref-type="fig"}). The subcellular patterns observed for EGFP-ORMDL1, EGFP-ORMDL2 and EGFP-ORMDL3 fusion proteins were similar, in either fixed (Figure [6g,6h,6i](#F6){ref-type="fig"}, respectively) or *in vivo* cells (Figure [6j,6k](#F6){ref-type="fig"}), co-localizing with an *in vivo* ER marker. Similar results were obtained from COS-7 cells transfected with either pEGFP-N2- or pEGFP-C2-derived constructs. In contrast, EGFP alone was uniformly distributed throughout the cell, including the nucleus (Figure [6l](#F6){ref-type="fig"}), in all experiments. Overall, these data show that the ORMDL proteins locate at the ER membrane in agreement with their predicted transmembrane topology.

*In situ* hybridization in *Drosophila* embryos and larval imaginal discs
-------------------------------------------------------------------------

We analyzed the expression pattern of the *Drosophila ORMDL* homolog (*DORMDL*) during different developmental stages. To this end, a 391 bp antisense riboprobe containing most of the coding sequence was used for *in situ* hybridization on wild-type Canton S *D. melanogaster* 0 h to 24 h embryos (stages 1 to 17). *DORMDL* was ubiquitously and homogeneously expressed in the syncytial blastoderm and during the cellularization stage (Figure [7a,7b](#F7){ref-type="fig"}). In stages 11-12, the germ-band layer (which later gives rise to all somatic cell lines, including ectoderm, mesoderm and endoderm) gave a positive hybridization signal (Figure [7c,7d](#F7){ref-type="fig"}). In later stages (stage 14), the signal was mainly detected in the ectodermal tissues (Figure [7e](#F7){ref-type="fig"}). The *DORMDL* riboprobe was also used to analyze the expression pattern in imaginal discs in third-instar larvae. Uniform and homogeneous expression was observed in eye-antenna, leg, wing, (Figure [7g,7h,7i](#F7){ref-type="fig"}) and haltere (data not shown) imaginal discs, which was consistent with the former ectodermal expression detected in late-stage embryos.

Yeast single and double knockouts: analysis of deletion strains
---------------------------------------------------------------

The *S. cerevisiae* genome contained two members of this family: *ORM1* (ORF YGR038w) at chromosome VII and *ORM2* (ORF YLR350w) at chromosome XII. To provide functional clues for the human homologs, we generated and analyzed single and double knockouts. We used the W303-1A and W303-1B yeast wild-type strains (see genotypes in Materials and methods) and the *kanMX4* cassette for gene disruption \[[@B10]\]. Single gene targetings were assessed by designing specific PCR reactions. The double knockout mutant was obtained by mating the two single knockout strains, subsequent sporulation, tetrad dissection and analysis of single spores. Verification of *ORM1* and *ORM2* gene integrity and/or deletion for the clones derived from each spore was carried out by independent PCRs with specific primers (Table [3](#T3){ref-type="table"}; Figure [8](#F8){ref-type="fig"}). Overall, 42 independent clones were analyzed, from which 23.8% were wild-type for *ORM1* and *ORM2* (and thus did not grow on G418-supplemented medium), 28.57% single *ORM1* deletants, 28.57% single *ORM2* deletants, 14.28% double knockouts and 4.76% diploids. The two single and double knockouts were viable and no morphological differences were detected between them and the wild-type cells. However, growth rates on rich media (YPD) differed: the double mutant grew much slower than the wild-type and single-knockout strains (data not shown).

A battery of tests was carried out to characterize the yeast mutants on the basis of their sensitivity or resistance to toxic compounds. The YPAD medium was supplemented with one of the following: dithiothreitol (DTT), tunicamycin, HgCl~2~, cycloheximide, CaCl~2~, KCl, caffeine, EGTA or SDS. In all cases the double-knockout strain was more sensitive to the toxic agent. In contrast, the growth of the single knockouts did not differ from that of the wild-type strain. This result was particularly evident in the plates supplemented with DTT, HgCl~2~ or tunicamycin (Figure [8b,8c](#F8){ref-type="fig"}). We also carried out complementation analyses with *ORMDL3,* the human counterpart with the greatest sequence similarity to yeast *ORM1* and *ORM2.* To this end, double-knockout yeast cells were transformed with either multicopy or centromeric expression vectors bearing *ORMDL3* under the control of a constitutive promoter, and dropout-plated in media supplemented with DTT, HgCl~2~ or tunicamycin. In all cases, some degree of phenotypic rescue was clearly observed, further arguing in favor of functional conservation in the *ORMDL* family (Figure [8c](#F8){ref-type="fig"}).

Discussion
==========

We report here the characterization of a novel gene family highly conserved in eukaryotes from yeast to mammals. Most of the species studied have more than one member of this gene family: *S. cerevisiae* and A. *thaliana* each contain two *ORMDL* genes, whereas three copies are present in vertebrates. On the other hand, *Encephalitozoon, Drosophila* and *Ciona* appear to contain a single *ORMDL* gene and no homologous sequence was found in *Caenorhabditis elegans.*

While this work was being carried out, many of the family members became incorporated in the genomic databases of the corresponding organisms, some only as predicted genes. However, even after a significant number of sequences had been annotated, the family had not been formally defined. This omission most probably reflects the fact that present annotations of gene families rely on previously characterized functional signatures or domains. In their absence, protein sequence comparisons remain as the only valuable tool.

A phylogenetic tree was constructed to study the evolutionary relationships between the *ORMDL* members (Figure [3](#F3){ref-type="fig"}). Several gene duplication events have taken place independently in different lineages, and have given rise to multiple copies in most of the species analyzed. The three human paralogs (*ORMDL1, ORMDL2* and *ORMDL3*) showed amino-acid identities of around 80%, whereas pairwise comparisons revealed more than 95% identity between human and mouse orthologs (Table [1](#T1){ref-type="table"}). Recently, genomic data derived from the complete genome sequence of the pufferfish *Takifugu rubripes* \[[@B11]\], cDNA annotation data in *Mus musculus* \[[@B12]\], and EST data collected from several vertebrate EST projects \[[@B4]\] support the evidence that the presence of three *ORMDL* genes - as characterized in humans - is common to all vertebrates. In addition, a single-copy *ORMDL* has been identified in the pre-vertebrate urochordate *C. intestinalis.* Overall, these data support the evidence that vertebrate *ORMDL* genes are true orthologs, probably arising by the postulated large-scale duplications, either genome doublings or extensive chromosomal duplications, in the vertebrate ancestry (\[[@B13]\] and references therein). In the human genome, the three *ORMDL* genes map within the large paralogous regions defined at 2q, 12q and 17q, which also include segments of chromosomes 7 and 3 \[[@B13],[@B14]\]. These regions contain the HOX clusters as well as two to four members of other families: *ORMDL1* and HOXD at 2q31-32; *ORMDL2* and HOXC at 12q13, and *ORMDL3* and HOXB at 17q21. Moreover, the HOX clusters in mammals are located within chromosomal regions that have maintained extensive chromosomal synteny throughout the vertebrates \[[@B15]\]. No further *ORMDL* sequences were found next to HOXA at 7p15 but, in this context, loss of a fourth copy is a feasible assumption.

In invertebrates, one *ORMDL* gene has been characterized in *Drosophila.* Although no sequence with amino-acid identities above 30% has been found in *Caenorhabditis elegans,* it is possible that a homolog will be identified as the worm genome assembly is completed. Alternatively, it could be argued that *ORMDL* may have been lost in the phylogenetic lineage that leads to the nematode, as has happened with some genes involved in developmental pathways, which are broadly represented in animal phylogeny but missing in *C. elegans* \[[@B16],[@B17]\].

In plants, different lineages show duplicated copies of *ORMDL* genes: the Solanaceae *Lycopersicon esculentum* (tomato) and *Solarium tuberosum* (potato; data not shown), the grasses *Sorghum bicolor* (sorghum) and *Zea mays* (maize; data not shown), and the brassica *Arabidopsis.* The two gene sequences found in *A. thaliana* and yeast are consistent either with the postulated genome duplications or large-scale segmental duplications in the *Arabidopsis* and *Saccharomyces* lineages \[[@B18],[@B19],[@B20]\]. Interestingly, the yeast *ORM1* and *ORM2* are located within duplicated chromosomal blocks in chromosomes VII and XII, respectively, which include 15 other paralogous gene pairs \[[@B19]\].

Protein alignment showed extended amino-terminal segments of around 20-60 amino acid residues for the yeast ORM proteins in comparison to the plant and animal forms. The conserved residues were mostly clustered in the middle segment of the protein chain. Transmembrane (TM) segment prediction yielded from two to four TM domains, (Table [2](#T2){ref-type="table"} and Figure [2](#F2){ref-type="fig"}). When using aligned sequences, four hydrophobic domains were apparent, and in most programs were recognized as putative TM sequences. Interestingly, the TM domains are conserved in their relative position but are much less conserved at the residue level than their flanking segments. In fact, the most conserved amino-acid segments are flanked by the two central hydrophobic domains, and probably indicate the location of an important functional domain. Whether this region is relevant to the reported association of yeast ORM2 with SLT2, a serine/threonine protein kinase of the MAP kinase family, remains to be proved \[[@B21]\]. Unfortunately, the reported interaction, from a comprehensive yeast proteome-wide two-hybrid analysis, has not been substantiated with further experimental data. In accordance with the TM prediction, subcellular localization using GFP fusion proteins showed ER anchorage of the human ORMDL proteins. Although co-localization with PDI was used to verify the ER-staining pattern, one cannot discard the possibility that overexpression could influence protein folding and trafficking. Further experiments to characterize protein topology are underway. Searches for signal peptides, nuclear-localization signals, protease-cleavage sites and conserved protein domains were also carried out but did not yield any significant similarities.

Human *ORMDL* homologs were ubiquitously expressed in adult and fetal samples with some minor tissue-specific differences. There was no evidence of alternative splicing affecting the coding region. However, the northern-blot analysis of *ORMDL1* revealed three transcripts of different size, which may be explained by the use of either different promoters or polyadenylation signals, and/or by alternative splicing affecting only the 5\'- or 3\'-UTRs. In fact, an alternative exon in the 5\'-UTR of *ORMDL1* is reported here.

Functional characterization of gene homologs in model organisms is an invaluable reference for investigating human genes with unknown function. In this respect, *Drosophila* is particularly informative when mutant strains for a specific gene are available. Unfortunately, neither P-element insertions next to *DORMDL* nor information on gene expression were available. Our data from *in situ* hybridization analysis in different developmental stages and imaginal discs showed ubiquitous expression at early embryonic stages, although at late stages the signal was stronger in the ectodermally derived tissues. Overall, these data support a basic cellular function for this gene family.

The search for additional functional clues prompted us to construct and analyze single and double yeast knockouts. Partial functional redundancy of the two yeast genes was deduced, as single mutants were viable and showed similar responses to the wild-type strain in sensitivity/resistance assays to toxic compounds. Deletion of both genes was not lethal, although yeast-cell growth and ability to respond to chemical aggression were partially affected in double knockouts. It is well known that DTT, a reducing agent that impairs disulfide bond formation, or tunicamycin, a glycosylation inhibitor that blocks the first step in the biosynthesis of *N*-linked oligosaccharides, induce the accumulation of unfolded proteins in the ER lumen. The cellular response to this type of stress (the unfolded protein response (UPR) pathway) eventually leads to the activation of several ER-resident protein chaperons and chaperon cofactors \[[@B22]\]. Given the ER-membrane localization of the ORMDL proteins and the higher sensitivity of the double knockouts to both tunicamycin and DTT, it is reasonable to postulate that these proteins participate in correct protein folding and/or trafficking in the ER, or are involved in the cellular UPR. Interestingly, phenotypic rescue of the double-knockout mutants was achieved by functional complementation with a human homolog, thus clearly supporting functional as well as structural evolutionary conservation of this gene family.

In summary, this study defines a novel eukaryotic gene family whose function is not yet clear. Several questions should be addressed in the future. They mainly concern protein topology, the cellular function of the family members and their association, if any, to human disease.

Materials and methods
=====================

Cloning of human *ORMDL1* cDNAs
-------------------------------

A PCR-derived probe of 647 bp was obtained from an IMAGE clone (220362, Research Genetics) using a primer pair (5\'-GGGAACAACTGGACTATG-3\' and 5\'-ACTTGTATAGAGAGGATTCC-3\') designed after the retinal EST H86933. This EST contained the STS WI-18706, which mapped to the *RP26* locus. The probe was labeled with \[α-^32^P\]dCTP by random priming (Roche Molecular Biochemicals) and was used to screen 10^6^ recombinant phages from a commercial λ gt10 retinal cDNA library (Clontech). Hybridization was carried out using standard protocols under highly stringent conditions \[[@B23]\]. Positive λ phages were isolated through several rounds of rescreening. Purified phage DNA was EcoRI-digested and inserts were subcloned into pBluescript II KS(+) (Stratagene). Sequencing was carried out using a ThermoSequenase II sequencing kit (Amersham Biosciences) and an ABI377 automatic sequencer (Applied Biosystems).

Rapid amplification of *ORMDL1* cDNA ends
-----------------------------------------

The 5\' and 3\' transcript ends were characterized using the SMART RACE cDNA amplification kit (Clontech) according to the manufacturer\'s instructions. Total RNA from human placenta was used for first-strand cDNA synthesis using SuperScript II RNase H^-^ reverse transcriptase (Invitrogen Life Technologies). The primers used were: 5\'-AGGAGCCTTGCTTTACCCTGGTCAG-3\' for the 5\'-RACE and 5\'-CAATGGCTGGTCCTTCAAGTGCTGT-3\' for the 3\'-RACE. The RACE products were subcloned using the SureClone ligation kit (Amersham Biosciences) and sequenced.

Characterization of human *ORMDL1* homologs
-------------------------------------------

BLAST searches \[[@B4],[@B5]\] against the EST section of the GenBank/EMBL databases identified sequences homologous to *ORMDL1,* which belonged to the two UniGene clusters Hs.13144 and Hs.293711. The IMAGE clones 212500, 221470, 1407036, 1407667, and 2364281 were obtained from the UK HGMP Resource Centre and sequenced.

Computer sequence analysis
--------------------------

A search for homologous protein sequences was carried out with tBLASTN, BLASTP, PSI-BLAST and PHI-BLAST programs at the NCBI BLAST server \[[@B4],[@B5]\]. Translated sequences were aligned using the program CLUSTALW \[[@B24]\], and visualized using the program Boxshade (created by Kay Hofmann and Michael D. Baron). Phylogenetic trees were constructed with the program CLUSTALW, excluding gap positions and correcting for multiple substitutions. Bootstrap analysis \[[@B25]\] was used for confidence evaluation. Potential transmembrane segments were predicted using the HMMTOP, TMAP and TMPRED programs \[[@B26],[@B27],[@B28]\]. Conserved protein domains and signal peptide searches were performed with reverse position-specific BLAST at the NCBI Conserved Domain Database, including Pfam and Smart databases \[[@B4],[@B5],[@B29],[@B30],[@B31]\]. Analysis of putative binding sites for transcription factors was carried out using the TESS server \[[@B7]\]. CpG islands were detected using the EMBL CpG Islands service \[[@B8]\]. The human *ORMDL* sequences were mapped using the BLAT program against the Human Genome Working Draft (December 22, 2001 assembly) at UCSC \[[@B32],[@B33]\].

Accession numbers of sequences used are as follows. This work: translations from AF395704 (HsapORMDL1), AF395705 (HsapORMDL2), and AF395708 (HsapORMDL3). From data banks: AAH02146 (MmusORMDL2), BAB26397 (MmusORMDL3), AAF51758 (DmelORMDL), AAK25947 (AthaORMDLa), BAB08433 (AthaORMDLb), CAA97026 (ScerORM1), AAB67252 (ScerORM2), CAA17924 (SpomORM), and translations from BE625123 (MmusORMDL1), AC098491 (RnorORMDL3), BI182456 (SscrORMDL1), BE588447 (BtauORMDL2), BM486897 (GgalORMDL2), BM489594 (GgalORMDL3), BJ037340 (XlaeORMDL1), BJ067072 (XlaeORMDL2), AL633210 (StroORMDL2), fugu clone T008329 (FrubORMDL1), fugu clone T005201 (FrubORMDL2), fugu clone T008602 (FrubORMDL3), AL591593 (DrerORMDL1), AL669202+AV885287 (CintORMDL), BE421632 (HvulORMDL), AW747032 (SbicORMDLa), AW678224 (SbicORMDLb), BG522023 (SrebORMDL), AI772256 (LescORMDLa), AI899675 (LescORMDLb), BM093316 (GmaxORMDL), BE202511 (MtruORMDL), BG140432 (LpenORMDLb), BE238653 (ZmayORMDLb), Y08688 (SmonORM1), and AL590450 (EcunORMDL).

Sequence data for this article were deposited with the GenBank data library under accession nos. AF395701 (*ORMDL1* exons 1, 2, and 3); AF395702 (*ORMDL1* exons 4 and 5); AF395704 (*ORMDL1* mRNA); AF395705, AF395706, AF395707 (*ORMDL2* mRNA); AF395708 (*ORMDL3* mRNA); AF395703 (*DORMDL* mRNA).

Characterization of the genomic region of *ORMDL1*
--------------------------------------------------

The human P1 genomic clone 1670, mapped to 2q31-2q33 \[[@B6]\], was obtained from Incyte Genomics. Plasmid DNA was obtained according to the supplier\'s instructions. Restriction fragments containing the *ORMDL1* exons were detected by Southern blot analysis using a full-length *ORMDL1* cDNA probe. Positive fragments were subcloned into pBluescript II KS(+), and sequenced. The size of intron 3 was determined by restriction mapping after PCR-amplification.

RT-PCR and northern blot analysis
---------------------------------

For RT-PCR expression analysis on 16 samples from adult and fetal tissues (Multiple Tissue cDNA Panels, Clontech), a pair of primers was designed for each human *ORMDL* gene to amplify the complete ORF, as follows: ORMDL1 forward: 5\'-CATGAACGTTGGAGTTGCC-3\', ORMDL1 reverse: 5\'-GTAAAATTTTTTTTCAGTTTCAAA-3\', ORMDL2 forward: GAAGAATGAATGTGGGGGTG-3\', ORMDL2 reverse: 5\'-CATGGAGCTGTCCCAAAAC-3\', ORMDL3 forward: 5\'-GCAGGATGAATGTGGGCACA-3\', ORMDL3 reverse: 5\'-GGCAGGGGAAGGGGCTGCA-3\'.

PCR amplifications were carried out in 25 μl reactions containing 2.5 μl template cDNA, 0.2 mM dNTPs, 5 μM each primer, 20 mM Tris-HCl, 50 mM KCl, 3 mM MgCl~2~, and 1 U Taq Platinum (Invitrogen Life Technologies). After an initial 3 min step at 94°C, reactions were subjected to 35 cycles of a denaturation step of 30 sec at 94°C, and an annealing-extension step of 45 sec at either 59°C (*ORMDL1*), 62°C (*ORMDL2*), or 65°C (*ORMDL3*). A final extension step was performed at 72°C for 5 min.

For northern blot analysis, radiolabeled full-length and 3\'-UTR *ORMDL1* cDNA probes were hybridized against a commercial human Multiple Tissue Northern blot (Clontech) using standard highly stringent conditions. A human actin probe was used as a control for RNA loading.

Cell culture, transient expression of *ORMDL1, ORMDL2* and *ORMDL3* fused to EGFP, immunolocalization, and confocal laser scanning microscopy
---------------------------------------------------------------------------------------------------------------------------------------------

COS-7 (African green monkey kidney) cells were routinely grown in DMEM containing 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml of penicillin and 100 μg/ml of streptomycin (Invitrogen Life Technologies). *ORMDL1, ORMDL2* and *ORMDL3* cDNAs were cloned in-frame either upstream or downstream of the gene for GFP using the pEGFP-N2 and pEGFP-C2 vectors (Clontech), respectively. All constructs were verified by sequencing. Transient transfections on COS-7 cells grown on coverslips were performed using the FuGENE reagent (Roche Molecular Biochemicals) following the manufacturer\'s protocol (the ratio was 1.5 μg DNA to 7.5 μl FuGENE). Empty pEGFP-N2 and pEGFP-C2 vectors were used as controls. Twenty-four hours after transfection, cells were rinsed with 100 mM PBS and fixed in 3% paraformaldehyde and 2% sucrose in 0.1 M phosphate buffer at 4°C for 45 min, then washed and permeabilized (if required) with 0.1% Triton X-100/20 mM glycine/10 mM PBS for 10 min. Following permeabilization, cells were rinsed and blocked in 0.5% BSA/20 mM glycine/10 mM PBS. Cells were incubated either with a specific anti-PDI primary antibody (permeabilized cells) or with biotin-labeled concanavalin A (Sigma) (non-permeabilized cells) at 37°C for 1 h. Upon washing, cells were incubated either with Rhodamine Red™-conjugated anti-rabbit secondary antibody (Jackson ImmunoResearch Laboratories) (permeabilized cells) or with Texas Red-streptavidin (Amersham Biosciences) (non-permeabilized cells) at 37°C for 45 min. *In vivo* co-localization with the ER marker (ER-Tracker Blue-White DPX, from Molecular Probes) was performed 24 h after transfection by rinsing coverslips twice with PBS followed by 30 min incubation at 37°C in a 4 μM ER-Tracker solution. All preparations were embedded in Vectashield mounting medium (Vector Laboratories). Fluorescence was analyzed with a Zeiss Axiophot epifluorescence microscope. Confocal laser scanning microscopy was performed with an Olympus IX-70 inverted laser scanning microscope.

Cloning of *D. melanogaster* cDNA
---------------------------------

A 529-bp probe was amplified by PCR from genomic *D. melanogaster* DNA. The primers used (5\'-TCAGTGCC-CTTCGTTAGC-3\' and 5\'-AGTGTTCCGTGTTGTTTC-3\') were designed after the high-throughput genomic sequences (GenBank) that were identified in a BLAST search using the human *ORMDL1* cDNA sequence. The radiolabeled probe was used to screen 8 × 10^5^ recombinant phages from an adult *D. melanogaster* cDNA library (Stratagene) constructed in Lambda ZAP II. Hybridization, washes, and autoradiography were carried out in standard conditions. After several rescreening rounds, pBluescript SK(+) plasmids containing the cDNA insert were excised from the isolated phages and sequenced.

*In situ* hybridization on *Drosophila* embryos and larval imaginal discs
-------------------------------------------------------------------------

Digoxigenin (DIG)-labeled antisense and sense riboprobes covering 84% of the *Drosophila ORMDL* ORF were synthesized using the DIG RNA labeling kit (Roche Molecular Biochemicals) according to the manufacturer\'s instructions. *Drosophila* embryos at different developmental stages were collected from a 24-h lay, dechorionated, fixed in 2% formaldehyde and 0.5 M EGTA in PBS, prehybridized for 1 h, and hybridized overnight at 55°C. After removing the hybridization solution and washing, embryos were incubated with 1/2000 anti-DIG antibody conjugated to alkaline phosphatase (Roche Molecular Biochemicals), preabsorbed against fixed embryos. The signal was detected with NBT/BCIP (Roche Molecular Biochemicals). Embryos were mounted on Permount, and examined and photographed under a Zeiss Axiophot microscope.

Wild-type *D. melanogaster* Canton S third-instar larvae were dissected in PBS and fixed in 4% paraformaldehyde in PBS for 20 min. After rinsing in PBS, a second round of fixation was performed in 4% paraformaldehyde in PBS with addition of 0.1% Triton X-100 and 0.1% deoxycholate. After further rinsing with PBS, the imaginal discs were dehydrated through a graded ethanol series. Further protocol steps before the hybridization were carried out as described \[[@B34]\] except that proteinase K digestion was omitted. After 1 h prehybridization at 60°C, the riboprobe was added hybridized overnight at 65°C. Thereafter, the discs were washed for 20 min each in a series of decreasing concentrations of hybridization solution in PBT at 65°C. Two final washes were done with PBT at room temperature. After 1 h of blocking with 2% BSA in PBT, the discs were incubated with preabsorbed anti-DIG, washed and detected as described above. Dissected discs were then mounted in glycerol, examined and photographed under a Zeiss Axiophot microscope.

Yeast strains and culture media
-------------------------------

*S. cerevisiae* W303-1A (*MAT***a**; *ura3-1, ade2-1, leu2-3,112; his3-11,15; trp1-*![](gb-2002-3-6-research0027-i2.gif)*; cam-100*) and W303-1B (*MAT*α; *ura3-1, ade2-1, leu2-3,112; his3-11,15; trp1-*![](gb-2002-3-6-research0027-i2.gif)*2; can1-100*) strains were grown on yeast extract peptone dextrose (YPD) media. G418-resistant strains were grown on YPD plates containing 200 mg/l of G418 sulphate (geneticin, Invitrogen Life Technologies).

Generation of yeast single knockouts and selection
--------------------------------------------------

To disrupt YGR038w and YLR350W ORFs, *kanMX4* substitution cassettes were PCR-amplified on plasmid pFA6a-kanMX4 \[[@B10]\] using two sets of primers with 18-19 nucleotide homology to the pFA6a MCS plus 45 nucleotide homology to the flanking regions of either YGR038w (*ORM1*) or YLR350W (*ORM2*) ORFs (Table [3](#T3){ref-type="table"}). One microgram of each gel-purified PCR product was used to transform yeast W303-1A and W303-1B strains by the lithium acetate method \[[@B35]\]. Transformed yeast cells were recovered by G418 selection. Homologous integration of the *kanMX4* cassette was verified by colony PCR. Two sets of primers were used for each gene to test for gene disruption and gene integrity, respectively (Table [3](#T3){ref-type="table"}). Primer design and PCR conditions essentially followed the EUROFAN guidelines \[[@B36]\].

Generation of yeast double knockouts
------------------------------------

The W303-1A Δorm1 (MAT**a**) and W303-1B Δorm2 (*MATα*) deletant strains were crossed to obtain the double heterozygous diploid strain. The reciprocal cross was also performed. The double heterozygous diploids were plated on sporulation medium (1% potassium acetate, 0.1% yeast extract, 0.05% dextrose, 2% agar) to induce meiosis \[[@B37]\]. Tetrad dissection and analysis were carried out as described \[[@B37]\]. Clones from spores were re-streaked on YPD plates containing 200 mg/l G418, and G418-resistant transformants were verified by colony PCR to assess single and double knockouts.

Qualitative phenotypic analysis of knockout strains
---------------------------------------------------

To test growth differences and sensitivity/resistance of the mutant strains against toxic compounds, single and double knockouts as well as wild-type clones were grown on liquid yeast extract peptone adenine dextrose (YPAD) medium for 14 h at 30°C, diluted to OD~600~ 0.1 and grown to OD~600~ 0.6-0.8. They were then sequentially diluted (5 dilutions, 1:5 each) with YPAD into the wells of microtiter plates and dropout-plated onto the corresponding test media (0.25 mM and 0.4 mM HgCl~2~; 10 mM and 15 mM DTT; 0.5 μg/ml and 1 μg/ml tunicamycin; 0.7 M CaCl~2~; 0.1% caffeine; 0.18 mg/ml and decreasing concentrations of cycloheximide; 3 mM EGTA; 1.5 M KCl; 0.01% SDS, all in YPAD). To test heat sensitivity, cultures were incubated in a water bath at 52°C for 35 min, sequentially diluted and plated on YPAD. We analyzed five independent clones for each mutant strain and three for each wild type, respectively.

Functional complementation assay with human *ORMDL3* in yeast double knockouts
------------------------------------------------------------------------------

A yeast centromeric plasmid, pSC16 \[[@B38]\] (kindly provided by S. Cervantes), and a non-centromeric plasmid (pVT-U) containing the *ADH1* promoter and termination expression cassettes were used to clone human *ORMDL3* ORF. Each construct (100 ng) was used to transform yeast W303 Δ*orm1* Δ*orm2* strain by the lithium acetate method. Transformed yeast cells were recovered by selection on minimal synthetic dropout (SD) medium without leucine (centromeric plasmid) or without uracil (non-centromeric plasmid). Transformants were grown on liquid YPAD, sequentially diluted and dropout-plated onto the corresponding test media (0.25 mM and 0.4 mM HgCl~2~; 10 mM and 15 mM DTT; 0.5 μg/ml and 1 μg/ml tunicamycin, all in YPAD).
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Figures and Tables
==================

![Nucleotide sequence of the *ORMDL1* cDNA. The translation is shown below. Intron positions are marked with black triangles. The exon shown between square brackets in the 5\'-UTR is alternatively spliced. Underlines mark the positions of the primers used for the RACE experiments.](gb-2002-3-6-research0027-1){#F1}

![Alignment of deduced ORMDL amino-acid sequences. Highly conserved positions (≥ 95%) are shown against a black background, whereas those with conservative exchanges are shown against a grey background. Alignment was performed using the CLUSTALW program \[23\]. Potential transmembrane segments (TM1 to TM4) are marked with bars above the alignment: Upper bars according to HMMTOP \[25\] and lower bars following TMAP \[26\]. Species abbreviations are as follows: Hsap, human; Mmus, mouse; Rnor, rat; Sscr, pig; Btau, cow; Ggal, chicken; Xlae, *Xenopus laevis*; Stro, *Silurana tropicalis*; Frub, *Takifugu rubripes* (pufferfish); Drer, *Danio rerio* (zebrafish); Cint, *Ciona intestinalis*; Dmel, *Drosophila melanogaster*; Atha, *Arabidopsis thaliana*; Hvul, *Hordeum vulgare* (barley); Sbic, *Sorghum vulgare*; Sreb, *Stevia rebaudiana*; Lesc, *Lycopersicon esculentum* (tomato); Gmax, *Glycine max* (soybean); Mtru, *Medicago truncatula*; Lpen, *Lycopersicon pennellii*; Zmay, *Zea mays* (maize); Scer, *Saccharomyces cerevisiae*; Smon, *Saccharomyces monacensis*; Spom, *Schizosaccharomyces pombe*; Ecun, *Encephalitozoon cuniculi*.](gb-2002-3-6-research0027-2){#F2}

![Relationships between the ORMDL amino-acid sequences shown as an unrooted phylogenetic tree. The tree was obtained with the program CLUSTALW \[23\], with distances corrected for multiple substitutions, and positions with gaps excluded. Numbers show results from bootstrap analysis \[4\]. The branches are labeled in the same manner as for the alignment (Figure [2](#F2){ref-type="fig"}).](gb-2002-3-6-research0027-3){#F3}

![Gene organization of human *ORMDL1, ORMDL2, ORMDL3,*![](gb-2002-3-6-research0027-i1.gif)*ORMDL1*, ![](gb-2002-3-6-research0027-i1.gif)*ORMDL2,* and *Drosophila ORMDL*. Exon numbers of *ORMDL1* are shown above the bars. Coding exons are shown in color and their sizes (in nucleotides) are: exon 3, 181 (orange); exon 4, 152 (yellow); exon 5, 133 (green). The intron sizes in kilobases are shown in-between the bars. The numbers below the bars denote the amino-acid positions for the exon-intron boundaries, and for the end of the ORF. The dotted appearance of the bar representing exon 2 of *ORMDL1* indicates that it is alternatively spliced. The structure of the two human pseudogenes is also shown. The chromosomal location of each gene or pseudogene is indicated to the right.](gb-2002-3-6-research0027-4){#F4}

![RT-PCR analyses of expression patterns of *ORMDL1*, *ORMDL2*, and *ORMDL3*. **(a)** Pattern of expression in a normalized panel of adult and fetal human tissues. **(b)** Northern blot hybridization using a *ORMDL1* probe (containing the whole coding region) against the mRNA of human adult tissues. The size of the three detected transcripts is shown. The same pattern was obtained using a probe containing the *ORMDL1* 3\'-UTR (data not shown).](gb-2002-3-6-research0027-5){#F5}

![ORMDL fused to EGFP at the amino or carboxyl terminus localizes in the perinuclear ER and throughout the ER network. **(a-c)** Confocal scanning microscopy of COS-7 cells transfected with ORMDL1-EGFP (a) co-localize with protein-disulfide isomerase (PDI) (b), an ER-marker protein, showing an overlapping signal in the endoplasmic reticulum (c). **(d-f)** Double-label fluorescence with biotin-labeled concanavalin A showed no overlapping signal with ORMDL1-EGFP at the plasma membrane. **(g-l)** COS-7 cells transfected with EGFP-ORMDL1, EGFP-ORMDL2 and EGFP-ORMDL3 fusion proteins were similar either in fixed (g, h, and i, respectively) and *in vivo* (j) cells, co-localizing with an *in vivo* ER marker (k). EGFP alone was uniformly distributed throughout the cell, including the nucleus (l).](gb-2002-3-6-research0027-6){#F6}

![Whole-mount *in situ* hybridization to detect *DORMDL* expression in *Drosophila* embryos and imaginal discs. *DORMDL* is ubiquitously expressed in the ectodermal tissues. **(a)** Syncytial blastoderm (stage 3/4, approximately 2 h); **(b)** cellular blastoderm focused in the plane where polar cells are visible (stage 5, 3 h-3 h 15 min); **(c)** lateral view of an stage 11 embryo with the fully stretched germ band; **(d)** lateral view of an stage 11-12 embryo when the germ band begins to recede; **(e)** lateral view of a stage 14 embryo; **(f)** sense probe (stage 13). A, anterior; P, posterior; D, dorsal; V, ventral; pc, polar cells; cel, cellularization; pro, procephalon; gb, germ band; T1-T3, thoracic segments; A1-A9, abdominal segments. Timings of developmental stages are approximate (development at 25°C). **(g)** Eye-antenna imaginal disc; **(h)** leg imaginal disc; **(i)** wing imaginal disc; **(j)** negative control - wing imaginal disc hybridized with the sense probe.](gb-2002-3-6-research0027-7){#F7}

![Qualitative phenotypic analysis of yeast knockout strains and functional complementation of human *ORMDL3*. **(a)** Genotype PCR analyses of spores derived from tetrad dissection. The deduced genotype for each clone is indicated above. Four different PCR reactions were performed to assess the following: lane 1, *ORM1* integrity; lane 2, *ORM1* deletion; lane 3, *ORM2* integrity; lane 4, *ORM2* deletion. **(b)** Dropout plate showing the growth of haploid wild-type, single-knockout and double-knockout strains. **(c)** Growth of wild-type, single-knockout and double-knockout strains as well as functional complementation of double knockouts transformed with human *ORMDL3*. pSC16-*hORMDL3* and pVT-U-*hORMDL3* denote, respectively, yeast centromeric and non-centromeric plasmid constructs used in the complementation assay. Five sequential dilutions (1:5 each) were plated, left to right, in YPAD medium supplemented with the toxic agents at the indicated concentrations.](gb-2002-3-6-research0027-8){#F8}

###### 

Percentage identity between members of the ORMDL family

  ------------ ------------ ------------ ------------ ------------ ------------ ------------ ----------- ------------ ------------ ---------- ---------- ---------- ---------
  HsapORMDL1   \-                                                                                                                                                   
  MmusORMDL1   99           \-                                                                                                                                      
  HsapORMDL2   83           82           \-                                                                                                                         
  MmusORMDL2   83           82           97           \-                                                                                                            
  HsapORMDL3   84           83           80           82           \-                                                                                               
  MmusORMDL3   84           84           81           83           96           \-                                                                                  
  DmelORMDL    48           48           50           50           50           50           \-                                                                     
  AthaORMDLa   40           41           39           39           41           41           35          \-                                                         
  AthaORMDLb   39           39           38           38           39           39           37          81           \-                                            
  ScerORM1     32           32           32           32           34           34           32          31           32           \-                               
  SmonORM1     33           33           34           33           36           36           33          32           32           92         \-                    
  ScerORM2     31           31           33           34           34           34           31          29           30           68         68         \-         
  SpomORM      39           39           39           40           41           41           35          31           34           48         49         46         \-
               HsapORMDL1   MmusORMDL1   HsapORMDL2   MmusORMDL2   HsapORMDL3   MmusORMDL3   DmelORMDL   AthaORMDLa   AthaORMDLb   ScerORM1   SmonORM1   ScerORM2   SpomORM
  ------------ ------------ ------------ ------------ ------------ ------------ ------------ ----------- ------------ ------------ ---------- ---------- ---------- ---------

The calculations are based on the alignment shown in Figure [2](#F2){ref-type="fig"}.

###### 

Summary of experimental and *in silico* data on the *ORMDL* gene family members

  Organism            Gene name    cDNA (bp)             Protein (amino acids)   Annotation (from RefSeq, GenBank, TAIR, FlyBase, SGD, YPD, PombePD)   Chromosomal location   Structural domains^\*^   Expression pattern^†^                                                                    Subcellular localization^†^
  ------------------- ------------ --------------------- ----------------------- --------------------------------------------------------------------- ---------------------- ------------------------ ---------------------------------------------------------------------------------------- -----------------------------
  *H. sapiens*        ORMDL1       1,092^†^              153                     LOC51240 \[39\]                                                       2q32.2                 4 TM                     Ubiquitous in adult and fetal tissues                                                    Endoplasmic reticulum
                      *ORMDL2*     934^†^                153                     HSPC160\[39\]                                                         12q13.2                3 TM                     Ubiquitous in adult and fetal tissues                                                    Endoplasmic reticulum
                      *ORMDL3*     869^†^                153                     None                                                                  17q21.1                4 TM                     Ubiquitous in adult and fetal tissues                                                    Endoplasmic reticulum
                      *ORMDL1*     (pseudogene)          None                    10p14                                                                 \-                     \-                       \-                                                                                       
                      *ORMDL2*     (pseudogene)          None                    8q22.1                                                                \-                     \-                       \-                                                                                       
  *M. musculus*       *ORMDL1*     1,815                 153                     None                                                                  1^‡^                   4 TM                     NT                                                                                       NT
                      *ORMDL2*     1,053                 153                     0610012C09 gene \[12\]                                                10^‡^                  4 TM                     NT                                                                                       NT
                      *ORMDL3*     2,024                 153                     2810011N17 gene \[12\]                                                11^‡^                  4 TM                     NT                                                                                       NT
  *T. rubripes*       *ORMDL1*     \-                    153                     None                                                                                         4 TM                     NT                                                                                       NT
                      *ORMDL2*     \-                    153                     None                                                                                         4 TM                     NT                                                                                       NT
                      *ORMDL3*     \-                    153                     None                                                                                         4 TM                     NT                                                                                       NT
  *C. intestinalis*   *ORMDL*      \-                    153                     None                                                                                         4 TM                     NT                                                                                       NT
  *D. melanogaster*   *ORMDL*      388^†^, partial cds   154                     CG14577 \[3\]                                                         3L 78E6                3 TM                     Ubiquitous at early embryonic stages and in ectodermal derived tissues at later stages   NT
  *A. thaliana*       *ORMDLa*     795                   157                     F6F3.4; At1g01230^§^                                                  1                      2 TM                     NT                                                                                       NT
                      *ORMDLb*     none                  154                     MJC20.10; At5g42000^¶^                                                5                      4 TM                     NT                                                                                       NT
  *S. cerevisiae*     *ORM1*^¥^    none                  222                     ORM1 \[40\]; G4089; YGR038w                                           VII                    4 TM                     NT                                                                                       NT
                      *ORM2*^\#^   none                  216                     YLR350w \[41\]; L8300.1                                               XII                    4 TM                     NT                                                                                       NT
  *S. monacensis*     *ORM1*       None                  222                     ORM1 \[40\]                                                                                  4 TM                     NT                                                                                       NT
  *S. pombe*          *ORM*        1167, partial cds     186                     SPBC119.09c \[42\]                                                    2                      3 TM                     NT                                                                                       NT
  *E. cuniculi*       *ORMDL*      \-                    147                     ECU11_1150 \[43\]                                                     XI                     4 TM                     NT                                                                                       NT

^\*^Potential transmembrane segments were predicted using the HMMTOP 2.0 program \[26\]. ^†^Experimental data obtained in the present study. ^‡^Mapping of mouse *ORMDL* genes was inferred from syntenic regions between human and mouse chromosomes. ^§^ GenBank accession no. AF360237. ^¶^GenBank accession no. NC_003076. ^¥^The null mutant constructed in the present study is viable; the double null mutant with ORM2 is viable but shows an impaired growth rate^†^; the *ORM1* mRNA is more abundant in *MATα* cells than in *MAT***a** cells, and at 39°C than at 30°C \[44\]; *ORM1* is coregulated with other 117 genes under 26 cell-damaging conditions \[45\] and is induced during sporulation \[46\]; Orm1 protein is produced in mid-log cells \[47\]. ^\#^The null mutant constructed in the present study is viable; the double null mutant with YGR038w (*ORM1*) is viable but shows an impaired growth rate^†^; Orm2 interacts with Slt2p in a systematic two-hybrid assay \[21\]; *ORM2* is coregulated with other 121 genes under 26 cell-damaging conditions \[45\] and is induced by a 30 min and 90 min treatment with 1 M NaCl \[48\]. TM, transmembrane segments; NT, not tested.

###### 

Primers used for the generation and verification of yeast single knockouts

  Oligonucleotides for the synthesis of *kanMX4* cassettes             
  -------------------------------------------------------------------- -------------------------------------------------------------------------------------------
  Primer                                                               Sequence 5\' to 3\'
   YGR038w F                                                           AGG AAC TGC TGA GGC GGC TTC TAC CTC GTA TAG TCG AAA TCA AAC **CGT ACG CTG CAG GTC GAC**
   YGR038w R                                                           TGT TCA ACT AAT TTG GGC GCG ACC TGT GAT ACC TGG GAT AGA AAT **ATC GAT GAA TTC GAG CTC G**
                                                                       
   YLR350w F                                                           ATC ATG ATT GAC CGC ACT AAA AAC GAA TCT CCA GCT TTT **GCG TAC GCT GCA GGT CGA C**
   YLR350w R                                                           CTA ACT AAT TTG AGC ACG GCC CGT AAT ACC AGG GAT GGA T**AT CGA TGA ATT CGA GCT CG**
  Oligonucleotides for gene integrity and gene deletion verification   
                                                                       
  Verification of *ORM1* gene integrity                                
   A1 (F)                                                              GTT TAG GAA CGG ATT ATA GA
   A2 (R)                                                              CTG GTC ATT TTC ATC TTC AA
  Verification of *ORM1* substitution                                  
   A1 (F)                                                              GTT TAG GAA CGG ATT ATA GA
   KAN5 (R)                                                            GTT CGG ATG TGA TGT GAG
  Verification of *ORM2* gene integrity                                
   YLR350w up400 (F)                                                   GCG TAT TTT GAT TGC TCA TA
   YLR350w ver (R)                                                     TGG TTT CAG GTT AGA CAC AT
  Verification of *ORM2* substitution                                  
   YLR350w up400 (F)                                                   GCG TAT TTT GAT TGC TCA TA
   KAN5 (R)                                                            GTT CGG ATG TGA TGT GAG

Oligonucleotides in bold are 18-19 nucleotide homology regions to pFA6a MCS sequences.
